{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T03:00:13Z","timestamp":1777950013617,"version":"3.51.4"},"reference-count":40,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T00:00:00Z","timestamp":1777852800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Patients with rheumatoid arthritis (RA) and concomitant fibromyalgia (FM) frequently experience severe, refractory pain, elevated disease activity scores, and substantial psychological distress. Conventional treatments frequently fail to adequately address this complex pain syndrome, and evidence-based traditional Chinese medicine (TCM) interventions for this specific comorbidity remain limited. This pilot study aimed to assess the feasibility of a definitive trial and preliminarily evaluate the efficacy and safety of\n                      <jats:italic>Shuhe granules<\/jats:italic>\n                      (SHG), a Chinese herbal formulation, for alleviating chronic pain and associated multidimensional symptoms in this patient population.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this randomized, double-blind, placebo-controlled pilot trial, 30 patients diagnosed with both RA and FM were randomly assigned (1:1) to receive either SHG (n = 15) or matching placebo (n = 15) twice daily for 4\u00a0weeks, followed by an 8-week follow-up. The primary outcome was the change in pain intensity measured by visual analog scale (VAS). Secondary outcomes included patient and physician global assessments (PGA, PhGA), tender and swollen joint counts (TJC, SJC), FM-specific measures (WPI, SSS, FIQ), and assessments of fatigue, sleep quality, anxiety, and depression. Safety was monitored through adverse event recording and laboratory tests.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Twenty-six patients completed the trial (placebo completers n = 11 vs. SHG n = 15). Linear mixed-effects models showed significant group \u00d7 time interactions for VAS (\n                      <jats:italic>P<\/jats:italic>\n                      &amp;lt; 0.001), PGA and PhGA (\n                      <jats:italic>P<\/jats:italic>\n                      &amp;lt; 0.001), and TJC (\n                      <jats:italic>P<\/jats:italic>\n                      &amp;lt; 0.001). Within the SHG group, VAS scores showed a clinically meaningful reduction at week 4 (\n                      <jats:italic>P<\/jats:italic>\n                      &amp;lt; 0.001), while no significant change occurred in the placebo group during the same period. TJC improvements persisted to week eight in the SHG group (\n                      <jats:italic>P<\/jats:italic>\n                      &amp;lt; 0.001). For FM-related outcomes, significant group \u00d7 time interactions were observed for SSS (\n                      <jats:italic>P<\/jats:italic>\n                      &amp;lt; 0.001) and PHQ-9 (\n                      <jats:italic>P<\/jats:italic>\n                      &amp;lt; 0.001), with the SHG group achieving clinically meaningful improvements in SSS at week 4 (\n                      <jats:italic>P<\/jats:italic>\n                      &amp;lt; 0.001) and significant reductions in PHQ-9 (\n                      <jats:italic>P<\/jats:italic>\n                      &amp;lt; 0.001). Although within-group improvements were also observed for FSS and ISI, between-group differences were not statistically significant. No serious adverse events occurred, and laboratory parameters remained within normal ranges for all participants.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This pilot study provides preliminary evidence that SHG may offer short-term benefits in reducing pain and improving physical function, sleep, fatigue, and psychological wellbeing in patients with RA and comorbid FM, with a safety profile comparable to placebo. While these preliminary findings support the potential of SHG as a therapeutic option, they require confirmation in larger, multicenter trials with extended follow-up to establish definitive efficacy and explore underlying mechanisms.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical Rehabilitation Impact<\/jats:title>\n                    <jats:p>SHG may represent a promising complementary therapy for relieving chronic pain and improving overall health in patients with RA complicated by FM. Larger, multicenter trials with extended follow-up are warranted to confirm these findings, explore underlying mechanisms, and define its role in integrative management strategies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical Trial Registration<\/jats:title>\n                    <jats:p>\n                      Chinese Clinical Trial Registry (ChiCTR),\n                      <jats:ext-link>https:\/\/www.chictr.org.cn\/showproj.html?proj=221912<\/jats:ext-link>\n                      , Identifier ChiCTR2400081980.18 March 2024.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fphar.2026.1761852","type":"journal-article","created":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T05:33:12Z","timestamp":1777872792000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Effects of Shuhe granules on chronic pain in patients with rheumatoid arthritis and fibromyalgia: a randomized, double-blind, placebo-controlled trial"],"prefix":"10.3389","volume":"17","author":[{"given":"Yi-hang","family":"Yu","sequence":"first","affiliation":[{"name":"State Key Laboratory of Traditional Chinese Medicine Syndrome, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine (Guangdong Provincial Hospital of Chinese Medicine), The Second Clinical Medical College of Guangzhou University of Chinese Medicine","place":["Guangzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-xi","family":"Li","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Traditional Chinese Medicine Syndrome, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine (Guangdong Provincial Hospital of Chinese Medicine), The Second Clinical Medical College of Guangzhou University of Chinese Medicine","place":["Guangzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meng-ling","family":"Peng","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Traditional Chinese Medicine Syndrome, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine (Guangdong Provincial Hospital of Chinese Medicine), The Second Clinical Medical College of Guangzhou University of Chinese Medicine","place":["Guangzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guang-yao","family":"Zhang","sequence":"additional","affiliation":[{"name":"Guangdong University of Technology","place":["Guangzhou, Guangdong, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai-xin","family":"Gao","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Traditional Chinese Medicine Syndrome, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine (Guangdong Provincial Hospital of Chinese Medicine), The Second Clinical Medical College of Guangzhou University of Chinese Medicine","place":["Guangzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hai-fang","family":"Du","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Traditional Chinese Medicine Syndrome, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine (Guangdong Provincial Hospital of Chinese Medicine), The Second Clinical Medical College of Guangzhou University of Chinese Medicine","place":["Guangzhou, China"]},{"name":"Guangdong Provincial Key Laboratory of Clinical Research on Traditional Chinese Medicine Syndrome","place":["Guangzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mao-jie","family":"Wang","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Traditional Chinese Medicine Syndrome, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine (Guangdong Provincial Hospital of Chinese Medicine), The Second Clinical Medical College of Guangzhou University of Chinese Medicine","place":["Guangzhou, China"]},{"name":"Guangdong Provincial Key Laboratory of Clinical Research on Traditional Chinese Medicine Syndrome","place":["Guangzhou, China"]},{"name":"State Key Laboratory of Dampness Syndrome of Chinese Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine (Guangdong Provincial Hospital of Chinese Medicine)","place":["Guangzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-dong","family":"Wu","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Traditional Chinese Medicine Syndrome, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine (Guangdong Provincial Hospital of Chinese Medicine), The Second Clinical Medical College of Guangzhou University of Chinese Medicine","place":["Guangzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen","family":"Xu","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Traditional Chinese Medicine Syndrome, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine (Guangdong Provincial Hospital of Chinese Medicine), The Second Clinical Medical College of Guangzhou University of Chinese Medicine","place":["Guangzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong-liang","family":"Chu","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Dampness Syndrome of Chinese Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine (Guangdong Provincial Hospital of Chinese Medicine)","place":["Guangzhou, China"]},{"name":"Zhuhai Branch of the Second Affiliated Hospital of Guangzhou University of Chinese Medicine","place":["Zhuhai, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bi-yun","family":"Xu","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Traditional Chinese Medicine Syndrome, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine (Guangdong Provincial Hospital of Chinese Medicine), The Second Clinical Medical College of Guangzhou University of Chinese Medicine","place":["Guangzhou, China"]},{"name":"Sleep disorder Department The Second Affiliated Hospital of Guangzhou University of Chinese Medicine","place":["Guangzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Run-yue","family":"Huang","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Traditional Chinese Medicine Syndrome, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine (Guangdong Provincial Hospital of Chinese Medicine), The Second Clinical Medical College of Guangzhou University of Chinese Medicine","place":["Guangzhou, China"]},{"name":"Guangdong Provincial Key Laboratory of Clinical Research on Traditional Chinese Medicine Syndrome","place":["Guangzhou, China"]},{"name":"State Key Laboratory of Dampness Syndrome of Chinese Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine (Guangdong Provincial Hospital of Chinese Medicine)","place":["Guangzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi-min","family":"Yang","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Traditional Chinese Medicine Syndrome, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine (Guangdong Provincial Hospital of Chinese Medicine), The Second Clinical Medical College of Guangzhou University of Chinese Medicine","place":["Guangzhou, China"]},{"name":"Sleep disorder Department The Second Affiliated Hospital of Guangzhou University of Chinese Medicine","place":["Guangzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,5,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1002\/smi.2992","article-title":"Differences in depression, anxiety and stress disorders between fibromyalgia associated with rheumatoid arthritis and primary fibromyalgia","volume":"37","author":"Alciati","year":"2021","journal-title":"Stress Health"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.3899\/jrheum.130493","article-title":"Chronic widespread pain in patients with rheumatoid arthritis and the relation between pain and disease activity measures over the first 5 years","volume":"40","author":"Andersson","year":"2013","journal-title":"J. Rheumatology"},{"key":"B3","doi-asserted-by":"publisher","first-page":"e10","DOI":"10.4088\/jcp.7131cc8c.e10","article-title":"Pain and the brain: chronic widespread pain","volume":"70","author":"Arnold","year":"2009","journal-title":"J. Clin. Psychiatry"},{"key":"B4","doi-asserted-by":"publisher","first-page":"2974","DOI":"10.1002\/art.20485","article-title":"A double\u2010blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder","volume":"50","author":"Arnold","year":"2004","journal-title":"Arthritis and Rheumatism Official J. Am. Coll. Rheumatology"},{"key":"B5","doi-asserted-by":"publisher","first-page":"R120","DOI":"10.1186\/ar2783","article-title":"The revised fibromyalgia impact questionnaire (FIQR): validation and psychometric properties","volume":"11","author":"Bennett","year":"2009","journal-title":"Arthritis Research and Therapy"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1136\/bjsports-2024-108369","article-title":"High-intensity interval training improves cardiovascular and physical health in patients with rheumatoid arthritis: a multicentre randomised controlled trial","volume":"58","author":"Bilberg","year":"2024","journal-title":"Br. Journal Sports Medicine"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1097475","DOI":"10.3389\/fnins.2023.1097475","article-title":"Effectiveness of non-pharmacological traditional Chinese medicine combined with conventional therapy in treating fibromyalgia: a systematic review and meta-analysis","volume":"17","author":"Cai","year":"2023","journal-title":"Front. Neurosci."},{"key":"B8","doi-asserted-by":"publisher","first-page":"8964","DOI":"10.3390\/ijerph19158964","article-title":"Psychosocial variables and healthcare resources in patients with fibromyalgia, migraine and comorbid fibromyalgia and migraine: a cross-sectional study","volume":"19","author":"Calandre","year":"2022","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"B9","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1007\/s11926-020-00921-8","article-title":"Therapeutic options and cost-effectiveness for rheumatoid arthritis treatment","volume":"22","author":"Drosos","year":"2020","journal-title":"Curr. Rheumatology Reports"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1093\/rheumatology\/key112","article-title":"Concomitant fibromyalgia complicating chronic inflammatory arthritis: a systematic review and meta-analysis","volume":"57","author":"Duffield","year":"2018","journal-title":"Rheumatology."},{"key":"B11","doi-asserted-by":"publisher","first-page":"i5239","DOI":"10.1136\/bmj.i5239","article-title":"CONSORT 2010 statement: extension to randomised pilot and feasibility trials","volume":"355","author":"Eldridge","year":"2016","journal-title":"Bmj"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1007\/s10067-021-06026-6","article-title":"Clinical and psychological assessment of patients with rheumatoid arthritis and fibromyalgia: a real-world study","volume":"41","author":"Gao","year":"2022","journal-title":"Clin. Rheumatol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1542897","DOI":"10.3389\/fphar.2025.1542897","article-title":"Shuhe granule for insomnia: study protocol for a double-blind, randomized, placebo-controlled trial","volume":"16","author":"Gao","year":"2025","journal-title":"Front. Pharmacol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s00296-010-1558-3","article-title":"Validation of the Turkish version of the fatigue severity scale in patients with fibromyalgia","volume":"32","author":"Gencay-Can","year":"2012","journal-title":"Rheumatol. International"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1007\/s00296-014-2972-8","article-title":"Fibromyalgia in patients with other rheumatic diseases: prevalence and relationship with disease activity","volume":"34","author":"Haliloglu","year":"2014","journal-title":"Rheumatol. International"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1007\/s00296-014-3010-6","article-title":"Traditional Chinese medicine versus western medicine as used in China in the management of rheumatoid arthritis: a randomized, single-blind, 24-week study","volume":"34","author":"He","year":"2014","journal-title":"Rheumatol. International"},{"key":"B17","doi-asserted-by":"publisher","first-page":"112230","DOI":"10.1016\/j.jep.2019.112230","article-title":"Best practice in research\u2013overcoming common challenges in phytopharmacological research","volume":"246","author":"Heinrich","year":"2020","journal-title":"J. Ethnopharmacology"},{"key":"B18","doi-asserted-by":"publisher","first-page":"953205","DOI":"10.3389\/fphar.2022.953205","article-title":"Best practice in the chemical characterisation of extracts used in pharmacological and toxicological research\u2014the ConPhyMP\u2014guidelines","volume":"13","author":"Heinrich","year":"2022","journal-title":"Front. Pharmacol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.jep.2015.10.024","article-title":"Characteristics of traditional Chinese medicine use in patients with rheumatoid arthritis in Taiwan: a nationwide population-based study","volume":"176","author":"Huang","year":"2015","journal-title":"J. Ethnopharmacol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s11655-020-3480-1","article-title":"Data mining study on prescription patterns of different dosage forms of Chinese herbal medicines for treating and improving immune-inflammatory indices in patients with rheumatoid arthritis","volume":"28","author":"Huang","year":"2022","journal-title":"Chin. J. Integr. Med."},{"key":"B21","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s11655-024-3768-7","article-title":"Efficacy and safety of Juan Bi pill with Add-on methotrexate in active rheumatoid arthritis: a 48-Week, Multicentre, randomized, Double-Blind, placebo-controlled trial","volume":"31","author":"Jia","year":"2025","journal-title":"Chin. J. Integr. Med."},{"key":"B22","doi-asserted-by":"publisher","first-page":"49","DOI":"10.3109\/03009742.2015.1052553","article-title":"Association of rheumatic diseases with symptom severity, quality of life, and treatment outcome in patients with fibromyalgia","volume":"45","author":"Jiao","year":"2016","journal-title":"Scand. Journal Rheumatology"},{"key":"B23","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/s11926-024-01159-4","article-title":"How to distinguish non-inflammatory from inflammatory pain in RA?","volume":"26","author":"Khot","year":"2024","journal-title":"Curr. Rheumatology Reports"},{"key":"B24","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1007\/s11655-019-3223-3","article-title":"On research progress of western and Chinese medicine treatment on pre-rheumatoid arthritis","volume":"25","author":"Kong","year":"2019","journal-title":"Chin. Journal Integrative Medicine"},{"key":"B25","doi-asserted-by":"publisher","first-page":"e70044","DOI":"10.1111\/jebm.70044","article-title":"Guidelines on treating fibromyalgia with nonpharmacological therapies in China","volume":"18","author":"Li","year":"2025","journal-title":"J. Evidence\u2010Based Med."},{"key":"B26","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1007\/s40744-020-00217-4","article-title":"Rheumatoid arthritis: the impact of mental health on disease: a narrative review","volume":"7","author":"Lwin","year":"2020","journal-title":"Rheumatology Therapy"},{"key":"B27","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1097\/BOR.0000000000000929","article-title":"Fibromyalgia and centralized pain in the rheumatoid arthritis patient","volume":"35","author":"Minhas","year":"2023","journal-title":"Curr. Opinion Rheumatology"},{"key":"B28","doi-asserted-by":"publisher","first-page":"CD004849","DOI":"10.1002\/14651858.CD004849.pub2","article-title":"Tai Chi for rheumatoid arthritis","volume":"9","author":"Mudano","year":"2019","journal-title":"Cochrane Database Syst. Rev."},{"key":"B29","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/j.eng.2019.01.018","article-title":"Traditional Chinese medicine as a treatment for rheumatoid arthritis: from empirical practice to evidence-based therapy","volume":"5","author":"Pan","year":"2019","journal-title":"Engineering"},{"key":"B30","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1002\/art.24430","article-title":"Association of concomitant fibromyalgia with worse disease activity score in 28 joints, health assessment questionnaire, and short form 36 scores in patients with rheumatoid arthritis","volume":"61","author":"Ranzolin","year":"2009","journal-title":"Arthritis Care and Res. Official J. Am. Coll. Rheumatology"},{"key":"B31","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1177\/00045632241285843","article-title":"Biomarkers in the diagnosis, prognosis and management of rheumatoid arthritis: a comprehensive review","volume":"62","author":"Sahin","year":"2025","journal-title":"Ann. Clin. Biochem."},{"key":"B32","first-page":"819","article-title":"Prevalence of musculoskeletal conditions in an Italian population sample: results of a regional community-based study. I. The MAPPING study","volume":"23","author":"Salaffi","year":"2005","journal-title":"Clin. Experimental Rheumatology"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.55563\/clinexprheumatol\/31gsnd","article-title":"The measurement of fibromyalgia severity: converting scores between the FIQR, the PSD and the FASmod","volume":"41","author":"Salaffi","year":"2023","journal-title":"Clin. Exp. Rheumatology"},{"key":"B34","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/1741-7015-8-18","article-title":"CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials","volume":"8","author":"Schulz","year":"2010","journal-title":"BMC Medicine"},{"key":"B35","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1016\/j.berh.2007.05.006","article-title":"The course of established rheumatoid arthritis","volume":"21","author":"Scott","year":"2007","journal-title":"Best Practice and Research Clin. Rheumatology"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1097\/j.pain.0000000000001830","article-title":"Bodily changes and sensory sensitivity in complex regional pain syndrome and fibromyalgia","volume":"161","author":"Ten Brink","year":"2020","journal-title":"Pain"},{"key":"B37","first-page":"695","article-title":"Severe rheumatoid arthritis (RA), worse outcomes, comorbid illness, and sociodemographic disadvantage characterize ra patients with fibromyalgia","volume":"31","author":"Wolfe","year":"2004","journal-title":"J. Rheumatology"},{"key":"B38","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1002\/acr.20140","article-title":"The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity","volume":"62","author":"Wolfe","year":"2010","journal-title":"Arthritis Care and Research"},{"key":"B39","doi-asserted-by":"publisher","first-page":"4348709","DOI":"10.1155\/2020\/4348709","article-title":"Efficacy and safety of integrated traditional Chinese medicine and Western medicine on the treatment of rheumatoid arthritis: a meta\u2010analysis","volume":"2020","author":"Xing","year":"2020","journal-title":"Evidence\u2010Based Complementary Altern. Med."},{"key":"B40","doi-asserted-by":"publisher","first-page":"101423","DOI":"10.1016\/j.berh.2019.06.005","article-title":"The prevalence and impact of comorbid fibromyalgia in inflammatory arthritis","volume":"33","author":"Zhao","year":"2019","journal-title":"Best Pract. and Res. Clin. Rheumatology"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1761852\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T05:33:13Z","timestamp":1777872793000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1761852\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,4]]},"references-count":40,"alternative-id":["10.3389\/fphar.2026.1761852"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2026.1761852","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,4]]},"article-number":"1761852"}}